Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

ReShape Lifesciences Inc (RSLS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ReShape Lifesciences's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.170 -0.002    -1.33%
16:53:15 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 13,764
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.167 - 0.177
ReShape Lifesciences 0.170 -0.002 -1.33%

ReShape Lifesciences Inc Company Profile

 
Get an in-depth profile of ReShape Lifesciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

40

Equity Type

ORD

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Contact Information

Address 1001 Calle Amanecer
San Clemente, 92673
United States
Phone 949 429 6680
Fax -

Top Executives

Name Age Since Title
Scott A. Shikora 63 2010 Member of Scientific Advisory Board
John Morton - 2018 Member of Scientific Advisory Board
Lori C. McDougal 62 2015 Independent Director
Jaime Ponce - 2018 Member of Scientific Advisory Board
Philip R. Schauer - 2018 Member of Scientific Advisory Board
Gary D. Blackford 66 2016 Independent Lead Director
Natan Zundel - 2018 Member of Scientific Advisory Board
Dan W. Gladney 70 2015 Executive Chair
Paul F. Hickey 58 2016 CEO, President & Director
Michael Orris - 2023 Member of Scientific Advisory Board
Michael Baptista - 2023 Member of Scientific Advisory Board
Christine Ren-Fielding - 2023 Member of Scientific Advisory Board
Shaw Somers - 2023 Member of Scientific Advisory Board
Darrin Hansen - 2023 Member of Scientific Advisory Board
Caroline M. Apovian - 2023 Member of Scientific Advisory Board
John Dixon - 2023 Member of Scientific Advisory Board
Carl Pesta - 2023 Member of Scientific Advisory Board
Adam Smith - 2023 Member of Scientific Advisory Board
Matt Brengman - 2023 Member of Scientific Advisory Board
Francesco Furbetta - 2023 Member of Scientific Advisory Board
Ardaeviraf Minocher Minocherhomjee 68 2018 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RSLS Comments

Write your thoughts about ReShape Lifesciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email